The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Comorbidities and Mortality in Persons With Schizophrenia: A Swedish National Cohort Study
Abstract
OBJECTIVE: Schizophrenia is associated with premature mortality, but the specific causes and pathways are unclear. The authors used outpatient and inpatient data for a national population to examine the association between schizophrenia and mortality and comorbidities. METHOD: This was a national cohort study of 6,097,834 Swedish adults, including 8,277 with schizophrenia, followed for 7 years (2003-2009) for mortality and comorbidities diagnosed in any outpatient or inpatient setting nationwide. RESULTS: On average, men with schizophrenia died 15 years earlier, and women 12 years earlier, than the rest of the population, and this was not accounted for by unnatural deaths. The leading causes were ischemic heart disease and cancer. Despite having twice as many health care system contacts, schizophrenia patients had no increased risk of nonfatal ischemic heart disease or cancer diagnoses, but they had an elevated mortality from ischemic heart disease (adjusted hazard ratio for women, 3.33 [95% CI=2.73-4.05]; for men, 2.20 [95% CI=1.83-2.65]) and cancer (adjusted hazard ratio for women, 1.71 [95% CI=1.38-2.10; for men, 1.44 [95% CI=1.15-1.80]). Among all people who died from ischemic heart disease or cancer, schizophrenia patients were less likely than others to have been diagnosed previously with these conditions (for ischemic heart disease, 26.3% compared with 43.7%; for cancer, 73.9% compared with 82.3%). The association between schizophrenia and mortality was stronger among women and the employed. Lack of antipsychotic treatment was also associated with elevated mortality. CONCLUSIONS: Schizophrenia patients had markedly premature mortality, and the leading causes were ischemic heart disease and cancer, which appeared to be underdiagnosed. Preventive interventions should prioritize primary health care tailored to this population, including more effective risk modification and screening for cardiovascular disease and cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cardiovascular disease emerges as the leading cause of premature mortality in individuals with SMI, as supported by substantial evidence [19–22].”
From A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China (2025) · cites this paper as [21]
In the citing paper
“The same method was used in a study from Sweden that found that persons with schizophrenia died 15 years (men) and 12 years (women) earlier than the general population (Crump et al. 2013).”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Crump et al. 2013
In the citing paper
“Evidence as to whether excess mortality is predominantly due to unnatural or natural causes of death remains equivocal.2,7,9,12”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“Conflicting results have been recently reported as to whether illicit drug use contributes to excess mortality in psychosis.2,25,26”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“People with schizophrenia and other psychotic disorders die earlier than their peers in the general population, with recent estimates suggesting by around 15–20 years.1–10”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“overall, findings on the association between exposure to antipsychotic medication and natural-cause mortality remain inconsistent.2,48,49”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“Over the past decades, consistent evidence has accrued that people with psychotic disorder have higher mortality rates than the general population.1–9”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
Citations
Cites
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
The unhealthy lifestyle of people with schizophrenia
Brown, S., Birtwistle, J., ROE, L., & THOMPSON, C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008186 · Cited by 880
Twenty-five year mortality of a community cohort with schizophrenia
Brown, S., Kim, M., Mitchell, C., & Inskip, H. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067512 · Cited by 601
Flagged first, then by citations
1 of the 50 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- National Board of Health and Welfare, 2011, Causes of Death 2010
- Garrett JM, 1997, Stata Technical Bulletin, 35, 9
- StataCorp, 2010, Stata Statistical Software: Release 11.0
- Ji J, Schizophr Bull
- van de Mheen PJ, 1996, Public Health Rep, 111, 420
- Lahti M, Psychol Med
Cited by
Sorted by citations
Items 201–300 of 618
Rozing, M. P., Jønsson, A. B. R., Køster‐Rasmussen, R., Due, T. D., Brodersen, J., Bissenbakker, K. H., Siersma, V., Mercer, S. W., Guassora, A. D., Kjellberg, J., et al. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00906-z · Cited by 20
Feeley, A. A., McDonnell, J. M., Feeley, I. H., & Butler, J. S. (2022) · Global Spine Journal · doi:10.1177/21925682211072849 · Cited by 21
Crapanzano, K. A., Deweese, S., Pham, D., Le, T., & Hammarlund, R. (2023) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-022-09829-w · Cited by 21
Solmi, M., Croatto, G., Fornaro, M., Schneider, L. K., Rohani-Montez, S. C., Fairley, L., Smith, N., Bitter, I., Gorwood, P. A. P. M., Taipale, H. T., et al. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.12.010 · Cited by 21
Nurjono, M., Tay, Y. H., & Lee, J. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.024 · Cited by 21
Crespo‐Facorro, B., Bernardo, M., Argimón, J. M., Arrojo, M., Bravo‐Ortiz, M. F., Cabrera-Cifuentes, A., Román, J. C., Franco, M., García‐Portilla, M. P., Haro, J. M., et al. (2016) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2016.09.001 · Cited by 28
Saiga, R., Uesugi, M., Takeuchi, A., Uesugi, K., Suzuki, Y., Takekoshi, S., Inomoto, C., Nakamura, N., Torii, Y., Kushima, I., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91233-z · Cited by 21
Solmi, M., Croatto, G., Fabiano, N., Wong, S., Gupta, A. A., Fornaro, M., Schneider, L. K., Rohani-Montez, S. C., Fairley, L., Smith, N., et al. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.11.001 · Cited by 22
Liberati, E. G., Kelly, S. A., Price, A. C., Richards, N., Gibson, J., Olsson, A., Watkins, S., Smith, E., Cole, S., Kuhn, I. L., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.103026 · Cited by 25
Zhang, Q., He, H., Bai, X., Jiang, L., Chen, W. J., Zeng, X., Li, Y., Teixeira, A. L., & Dai, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.702720 · Cited by 20
Paulzen, M., Haen, E., Gründer, G., Lammertz, S. E., Stegmann, B., Schruers, K. R. J., Walther, S., & Schoretsanitis, G. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116650390 · Cited by 20
Blomqvist, M., Ivarsson, A., Carlsson, I., Sandgren, A., & Jormfeldt, H. (2019) · Issues in Mental Health Nursing · doi:10.1080/01612840.2019.1642425 · Cited by 22
Mortality in people with psychotic disorders in Finland: A population-based 13-year follow-up study
Keinänen, J., Mantere, O., Markkula, N., Partti, K., Perälä, J., Saarni, S. I., Härkänen, T., & Suvisaari, J. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.048 · Cited by 29
Stubbs, B., Soundy, A., Probst, M., Parker, A., Skjærven, L. H., Gyllensten, A. L., & Vancampfort, D. (2013) · Physiotherapy · doi:10.1016/j.physio.2013.11.003 · Cited by 20
Psychosocial therapies in severe mental illness: update on evidence and recommendations
Gühne, U., Weinmann, S., Riedel-Heller, S. G., & Becker, T. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000618 · Cited by 19
Gühne, U., Pabst, A., Kösters, M., Hasan, A., Falkai, P., Kilian, R., Allgöwer, A., Ajayi, K., Baumgärtner, J., Brieger, P., et al. (2022) · Journal of Occupational Medicine and Toxicology · doi:10.1186/s12995-022-00345-3 · Cited by 19
The Protective Effect of Clozapine on Suicide
Lee, B. J., Cotes, R. O., Mojtabai, R., Margolis, R. L., Nucifora, F. C., & Nestadt, P. S. (2023) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.22m14587 · Cited by 21
Health disparities among breast cancer patients with/without disabilities in Germany
Groß, S. E., Pfaff, H., Swora, M., Ansmann, L., Albert, U., & Groß-Kunkel, A. (2019) · Disability and health journal · doi:10.1016/j.dhjo.2019.100873 · Cited by 19
Ma, Y., Li, J., Xu, Y., Wang, Y., Yao, Y., Liu, Q., Wang, M., Zhao, X., Fan, R., Chen, J., et al. (2020) · Aging · doi:10.18632/aging.102735 · Cited by 17
Irwin, K. E., Steffens, E. B., Yoon, Y., Flores, E. J., Knight, H. P., Pirl, W. F., Freudenreich, O., Henderson, D. C., & Park, E. R. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201900044 · Cited by 20
Real‐world effectiveness of antipsychotics
Tiihonen, J. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12641 · Cited by 19
Expanding Access to Cancer Clinical Trials for Patients With Mental Illness
Irwin, K. E., Moy, B., Fields, L. E., Callaway, C. A., Park, E. R., & Wirth, L. J. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01881 · Cited by 19
Shan, H., Li, F. R., Zhang, J., Wang, H., & Li, J. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.671631 · Cited by 18
Jia, N., Li, Z., Li, X., Jin, M., Liu, Y., Cui, X., Hu, G., Liu, Y., He, Y., & Yu, Q. (2022) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2021-2306 · Cited by 17
Doane, M. J., Raymond, K., Saucier, C. D., Bessonova, L., O’Sullivan, A. K., White, M. K., Foster, A. M., LaGasse, K., Carpenter-Conlin, J., Sajatovic, M., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04746-4 · Cited by 20
Solmi, M., Croatto, G., Gupta, A. A., Fabiano, N., Wong, S., Fornaro, M., Schneider, L. K., Rohani-Montez, S. C., Fairley, L., Smith, N., et al. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.07.009 · Cited by 20
Vita, A., Barlati, S., Cavallaro, R., Mucci, A., Riva, M. A., Rocca, P., Rossi, A., & Galderisi, S. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1451832 · Cited by 28
Physical health status of older adults with severe mental illness: The PH i SMI ‐E cohort study
Houben, N., Janssen, E. P. C. J., Hendriks, M. R., van der Kellen, D., van Alphen, B., & van Meijel, B. (2018) · International Journal of Mental Health Nursing · doi:10.1111/inm.12547 · Cited by 18
Jahrami, H., Faris, M. E., Ghazzawi, H., Saif, Z., Habib, L., Shivappa, N., & Hébert, J. R. (2019) · Nutrients · doi:10.3390/nu11081867 · Cited by 19
Rawat, V. S., Ganesh, S., Bijjal, S., Reddy, K. S., Agarwal, V., Devi, R., Kumar, C. N., Christopher, R., & Thirthalli, J. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.039 · Cited by 18
Ösby, U., Olsson, E., Edman, G., Hilding, A., Eriksson, S. V., & Östenson, C. G. (2013) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2013.797022 · Cited by 17
Drug Use and Mental Health: Comorbidity between Substance Use and Psychiatric Disorders
Sullivan, M. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-84834-7_1 · Cited by 20
Ljungman, C. E. A., Kahan, T., Schiöler, L., Hjerpe, P., Wettermark, B., Boström, K. B., & Manhem, K. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2014.100 · Cited by 17
Farholm, A., Sørensen, M., Halvari, H., & Hynnekleiv, T. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1528-3 · Cited by 26
Jormfeldt, H., Doyle, L., Ellilä, H., Lahti, M., Higgins, A., Keogh, B., Meade, O., Stickley, T., Sitvast, J. E., Skärsäter, I., et al. (2018) · International Journal of Qualitative Studies on Health and Well-Being · doi:10.1080/17482631.2018.1502013 · Cited by 16
Kalinowska, S., Trześniowska-Drukała, B., Safranow, K., Pełka-Wysiecka, J., Kłoda, K., Misiak, B., & Samochowiec, J. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.02.029 · Cited by 17
Chorioamnionitis and risk of long-term neurodevelopmental disorders in the offspring: a response
Tsamantioti, E., & Razaz, N. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.04.005 · Cited by 17
Health-related quality of life and metabolic risk in patients with psychosis
Foldemo, A., Wärdig, R. E., Bachrach‐Lindström, M., Edman, G., Holmberg, T., Lindström, T., Valter, L., & Ösby, U. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.11.029 · Cited by 16
D2 dopamine receptor gene (DRD2) Taq1A (rs1800497) affects bone density
Chiang, T.-I., Lane, H., & Lin, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-70262-0 · Cited by 16
Park, S. J., Wai, A., Pavithran, K., Kunheri, B., & Valsraj, K. M. (2021) · Psycho-Oncology · doi:10.1002/pon.5796 · Cited by 16
Starzer, M. S. K., Hansen, H. G., Hjorthøj, C. R., Speyer, H., Albert, N., & Nordentoft, M. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad111 · Cited by 16
Viron, M., Zioto, K., Schweitzer, J., & Levine, G. (2014) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2014.03.009 · Cited by 19
Is the risk of antipsychotic polypharmacy discontinuation dependent on the agents used?
Constantine, R. J., Andel, R., McPherson, M., & Tandon, R. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.09.050 · Cited by 16
Mishu, M. P., Uphoff, E., Aslam, F., Philip, S., Wright, J. M., Tirbhowan, N., Ajjan, R., Azdi, Z. A., Stubbs, B., Churchill, R. C., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013281.pub2 · Cited by 18
Management of Cardiovascular Health in People with Severe Mental Disorders
Lemogne, C., Blacher, J., Airagnes, G., Hoertel, N., Czernichow, S., Danchin, N., Meneton, P., Limosin, F., & Fiedorowicz, J. G. (2021) · Current Cardiology Reports · doi:10.1007/s11886-020-01436-5 · Cited by 17
Chan, J. K. N., Wong, C. S. M., Yung, N. C. L., Chen, E. Y. H., & Chang, W. C. (2021) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-021-02130-9 · Cited by 16
Stubbs, B., Soundy, A., Probst, M., Binder, M. D., Herdt, A. D., Parker, A., & Vancampfort, D. (2014) · Physiotherapy Research International · doi:10.1002/pri.1592 · Cited by 17
Wu, C., & Gau, S. S. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv187 · Cited by 15
Probable clozapine-induced parenchymal lung disease and perimyocarditis: a case report
Bugge, E., Nissen, T., & Wynn, R. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1158-1 · Cited by 16
Korge, J., & Nunan, D. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.11.030 · Cited by 16
Antipsychotics and risk of natural death in patients with schizophrenia
Chen, Y., Yang, X., Qin, X., Yang, Q., Fan, H., Li, J., Song, X., Xu, S., Guo, W., Deng, W., et al. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s199748 · Cited by 17
The role of comorbidity in the association of obesity with unemployment and disability
Strat, Y. L., Melchior, M., Gorwood, P. A. P. M., Tebeka, S., & Dubertret, C. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.03.004 · Cited by 18
Mishu, M. P., Peckham, E. J., Wright, J. M., Taylor, J., Tirbhowan, N., Ajjan, R., Azdi, Z. A., Stubbs, B., Churchill, R. C., & Siddiqi, N. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013281 · Cited by 15
Doğu, S. E., & Örsel, S. (2022) · Australian Occupational Therapy Journal · doi:10.1111/1440-1630.12855 · Cited by 15
Lundström, S., Jormfeldt, H., Ahlström, B. H., & Skärsäter, I. (2018) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2018.12.002 · Cited by 15
Increased peripheral levels of TARC/CCL17 in first episode psychosis patients
Malmqvist, A., Schwieler, L., Orhan, F., Fatouros‐Bergman, H., Bauer, M., Flyckt, L., Červenka, S., Engberg, G., Piehl, F., & Erhardt, S. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.12.033 · Cited by 15
Andreou, D., Saetre, P., Fors, B. M., Nilsson, B. M., Kullberg, J., Jönsson, E. G., Barbier, C. E., & Agartz, I. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.12.042 · Cited by 15
Physical and psychiatric comorbidities among patients with severe mental illness as seen in Uganda
Mpango, R. S., Ssembajjwe, W. J., Rukundo, G. Z., Birungi, C., Kalungi, A., Gadow, K. D., Patel, V., Nyirenda, M., & Kinyanda, E. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01478-6 · Cited by 15
Gal, G., Munitz, H., & Levav, I. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000852 · Cited by 15
Comorbidity of schizophrenia and infection: a population-based cohort study
Nielsen, P. R., Laursen, T. M., & Agerbo, E. (2016) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1297-1 · Cited by 15
Castle, D. J., & Chung, E. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1419946 · Cited by 15
Depot/Long Acting Antipsychotics in the Treatment of Schizophrenia and Bipolar Disorder
Özgüven, H. D., & Kır, Y. (2021) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.27480 · Cited by 14
Jaén‐Moreno, M. J., Rico‐Villademoros, F., Ruiz-Rull, C., Laguna-Muñoz, D., del Pozo, G. I., & Sarramea, F. (2023) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2022.2154646 · Cited by 14
Stenberg, H., Li, X., Pello-Esso, W., Lönn, S. L., Thønnings, S., Khoshnood, A., Knudsen, J. D., Sundquist, K., & Jansåker, F. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102326 · Cited by 16
Self-citationThe role of infections and inflammation in schizophrenia: review of the evidence
Ahmed, G. K., Ramadan, H. K., Elbeh, K., & Haridy, N. A. (2024) · Middle East Current Psychiatry · doi:10.1186/s43045-024-00397-7 · Cited by 16
Predictors of adherence to exercise interventions in people with schizophrenia
Schwaiger, R., Maurus, I., Lembeck, M., Papazova, I., Greska, D., Muenz, S., Sykorova, E. B., Thieme, C. E., Vogel, B. O., Mohnke, S., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01789-w · Cited by 15
Paliperidone palmitate: Japanese postmarketing mortality results in patients with schizophrenia
Pierce, P. F., Gopal, S., Savitz, A. J., Qiu, H., Hino, T., Busch, M., Fujino, A., Mathews, M., Katsu, T., Maeda, Y., et al. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1198755 · Cited by 14
Health Risks among People with Severe Mental Illness in Psychiatric Outpatient Settings
Blomqvist, M., Ivarsson, A., Carlsson, I., Sandgren, A., & Jormfeldt, H. (2018) · Issues in Mental Health Nursing · doi:10.1080/01612840.2017.1422200 · Cited by 14
Yang, F., Ma, Q., Liu, J., Ma, B., Guo, M., Liu, F., Li, J., Wang, Z., & Liu, M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000996 · Cited by 15
Joe, P., Clemente, J. C., Piras, E., Wallach, D. S., Robinson‐Papp, J., Boka, E., Remsen, B., Bonner, M., Kimhy, D., Goetz, D. M., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.09.019 · Cited by 14
Kirschner, V. S., Lamp, N., Dinc, Ü., Becker, T. M., Kilian, R., & Mueller‐Stierlin, A. S. (2022) · BMC Psychiatry · doi:10.1186/s12888-021-03640-1 · Cited by 16
Rathmann, W., Pscherer, S., Konrad, M., & Kostev, K. (2015) · Primary care diabetes · doi:10.1016/j.pcd.2015.04.001 · Cited by 14
The prevalence and risk factors of stroke in patients with chronic schizophrenia
Liang, Y., Huang, J. V., Tian, J., Cao, Y., Zhang, G., Wang, C., Cao, Y., & Li, J. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s106663 · Cited by 14
Sleep quality in patients with schizophrenia: The relevance of physical activity
Costa, R., Bastos, T. C. L., Probst, M., Seabra, A., Vilhena, E., & Corredeira, R. (2018) · Mental health and physical activity · doi:10.1016/j.mhpa.2018.04.004 · Cited by 15
The pharmacological treatment of schizophrenia: how far have we come?
Rubio, J. M., & Kane, J. M. (2022) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.13 · Cited by 13
Sakinyte, K., & Holmberg, C. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04701-3 · Cited by 13
Flores, E. J., Neil, J. M., Tiersma, K. M., Pappano, C. R., Mulligan, C. K., Alphen, M. U. V., Park, E. R., & Irwin, K. E. (2021) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2021.07.010 · Cited by 13
Schizophrenia and co-morbidity risk: Evidence from a data driven phenomewide association study
Mulugeta, A., Suppiah, V., & Hyppönen, E. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.04.010 · Cited by 14
Chen, P., Tsai, S., Pan, C., Chang, C., Su, S., Chen, C., & Kuo, C. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13116 · Cited by 12
Crespo‐Facorro, B., Bernardo, M., Argimón, J. M., Arrojo, M., Bravo‐Ortiz, M. F., Cabrera-Cifuentes, A., Román, J. C., Franco, M., García‐Portilla, M. P., Haro, J. M., et al. (2017) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2016.09.002 · Cited by 13
Özaslan, Z., Bilgin, H., Yalçın, S. U., & Haddad, M. (2019) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12553 · Cited by 15
Wang, T., Bendayan, R., Msosa, Y. J., Pritchard, M., Roberts, A., Stewart, R. J., & Dobson, R. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104010 · Cited by 11
Smith, G. R. (2014) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2014.10.009 · Cited by 12
Risk of cardiovascular disease in people taking psychotropic medication: a literature review
Mwebe, H. P., & Roberts, D. A. (2019) · British Journal of Mental Health Nursing · doi:10.12968/bjmh.2018.0033 · Cited by 12
BMI-NECK: A simple assessment of risk of obstructive sleep apnea in schizophrenia
Szaulińska, K., & Wichniak, A. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.03.005 · Cited by 12
Chen, Y., Chen, H., Wu, B., Chen, I., Chen, J., Lin, C., & Hsiao, T. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.08.032 · Cited by 12
Chen, V. C., Liao, Y., Lai, T.-J., Lane, H., Shao, W., Dewey, M. E., Lee, C. T., & Lu, M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.10.005 · Cited by 14
Etoh, T., Fujiwara, M., Yamada, Y., Wada, R., Higuchi, Y., Inoue, S., Kodama, M., Matsushita, T., Yoshimura, Y., Horii, S., et al. (2021) · Psycho-Oncology · doi:10.1002/pon.5780 · Cited by 11
Popa, A.-V., Ifteni, P. I., Țâbian, D., Petric, P. S., & Teodorescu, A. (2025) · Schizophrenia · doi:10.1038/s41537-025-00667-1 · Cited by 11
Jørgensen, A., Knorr, U., Soendergaard, M. G., Lykkesfeldt, J., Fink‐Jensen, A., Poulsen, H. E., Jørgensen, M. B., Olsen, N. V., & Staalsø, J. M. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0455-4 · Cited by 11
Buhagiar, K., Templeton, G., Blyth, H., Dey, M., & Giacco, D. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.08.026 · Cited by 11
Wei, D., Wang, Y., Deng, S.-Y., Cohen, A., Luo, W. P., Liu, B., & Ran, M. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103075 · Cited by 11
Physical Health Impairment and Exercise as Medicine in Severe Mental Disorders: A Narrative Review
Brobakken, M. F., Nygård, M., & Wang, E. (2022) · Sports Medicine - Open · doi:10.1186/s40798-022-00490-3 · Cited by 11
Breast Cancer Screening Among Females With and Without Schizophrenia
O’Neill, B. G., Yusuf, A., Lofters, A., Huang, A., Ekeleme, N. C., Kiran, T., Greiver, M., Sullivan, F., & Kurdyak, P. A. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.45530 · Cited by 11
Islam, M. A., Khan, M., Quee, P. J., Snieder, H., van den Heuvel, E. R., Bruggeman, R., Alizadeh, B. Z., GROUP Investigators, van Beveren, N. J. M., Cahn, W., et al. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.05.001 · Cited by 10
Brooks, J., BLAKE, J. G., Sánchez, J., Mpofu, E., Wu, J.-R., Chen, X., Nauser, J., Cotton, B. P., & Bartels, S. J. (2019) · Community Mental Health Journal · doi:10.1007/s10597-019-00403-x · Cited by 11
High Risk and Trajectories of Physical Illnesses before the Diagnosis of Bipolar Disorder
Chen, P., Tsai, S., Pan, C., Chen, Y., Chang, H., Su, S., Chen, C., & Kuo, C. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.127 · Cited by 11
Aschbrenner, K. A., Naslund, J. A., Salwen‐Deremer, J. K., Browne, J., Bartels, S. J., Wolfe, R. S., Xie, H., & Mueser, K. T. (2021) · Early Intervention in Psychiatry · doi:10.1111/eip.13129 · Cited by 13
Aagaard, J., Buus, N., Wernlund, A. G., Foldager, L., & Merinder, L. B. (2016) · International Journal of Social Psychiatry · doi:10.1177/0020764016642490 · Cited by 11
Doshi, J. A., Li, P., Desai, S. M., & Marcus, S. C. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1365720 · Cited by 11
Metadata
- Authors
- Crump, C., Winkleby, M. A., Sundquist, K., & Sundquist, J.
- Affiliations
- Lund University (SE)
- Venue
- American Journal of Psychiatry
- Published
- 2013-03
- Volume
- 170
- Issue
- 3
- Pages
- 324-333
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2157959378
- Cited by
- 619
- References
- 50
- Citations by year
- 2026: 20 · 2025: 28 · 2024: 49 · 2023: 58 · 2022: 47 · 2021: 51 · 2020: 58 · 2019: 63 · 2018: 40 · 2017: 59 · 2016: 40 · 2015: 39 · 2014: 46 · 2013: 20
- FWCI
- 34.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institute on Drug Abuse (R01DA030005)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, premature mortality, comorbidities, ischemic heart disease, cancer, sex differences, employment status, antipsychotic drugs, underdiagnosis, cardiovascular screening, cancer screening, primary care
- MeSH terms
- Adult, Aged, Aged, 80 and over, Ambulatory Care, Cause of Death, Female, Hospitalization, Humans, Life Expectancy, Male, Middle Aged, Neoplasms, Risk, Schizophrenia, Sweden, Cohort Studies, Comorbidity, Myocardial Ischemia, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
